临床试验

Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE III)

NCT：NCT04065490 · COMPLETED

NCT编号NCT04065490

状态COMPLETED

开始日期2019-09-23

完成时间2024-11-01

SponsorLumiThera, Inc. (INDUSTRY)

First posted2019-08-22

Last updated2026-10-08

简要摘要

This LIGHTSITE III study is a double-masked, sham-controlled, parallel design, prospective multi-site study for the use of PBM as a treatment for visual impairment in subjects with dry AMD. Alcon Research, LLC, acquired LumiThera in September 2025.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。